Dudediligence.

Precision BioSciences, Inc

DTILNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$576,000Sep ’24$638,000Dec ’24$29,000Mar ’25$18,000Jun ’25$13,000Sep ’25$34.2MDec ’25$10.8MMar ’26$0.00Jun ’26
Net income, by quarter
−$16.4MSep ’24−$17.7MDec ’24−$20.6MMar ’25−$23.5MJun ’25−$21.8MSep ’25$20.1MDec ’25−$18.4MMar ’26−$32.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$115.5M$25.1M$48.7M$68.7M$34.3M
Operating income−$39.4M−$62.3M−$43.7M−$26.2M−$52.1M
Net income−$30.6M−$111.6M−$61.3M$7.2M−$45.7M
Operating cash flow−$10.9M−$45.8M−$84.1M−$58.4M−$65.8M
Free cash flow−$15.9M−$49.1M−$86.1M−$58.7M−$65.9M
Cash$143.7M$189.6M$116.7M$85.9M$110.8M
Debt$2.5M$22.2Mnone on filenone on filenone on file
Shares outstanding60.9M3.7M4.2M8.2M24.1M